Pulmonary aspergillosis in an immunocompromised patient diagnosed with severe COVID-19 in the State of Pará, Brazil
DOI:
https://doi.org/10.33448/rsd-v14i1.48055Keywords:
Aspergillus, Diabetes mellitus, Immunosuppression, Covid-19, Invasive fungal infections.Abstract
Aspergillosis is a fungal infection caused by Aspergillus spp, a saprotrophic fungus found mainly in soil and in residential and hospital environments. This lung disease can affect immunocompromised individuals, and the presence of comorbidities increases susceptibility to fungal infection. Affected individuals may present with recurrent hemoptysis, chronic cough, purulent sputum, recurrent respiratory infections, pleuritic pain, and respiratory distress. The study aims to describe a case of pulmonary aspergillosis in an immunocompromised patient in the state of Pará. This is an observational and descriptive study. The information was obtained through interviews, medical record analysis, and literature review. The correlation between hospitalization, diabetes mellitus, and COVID-19 infection in the context of pulmonary aspergillosis is complex, involving immunological, environmental, and microbiological factors. The patient presented has a history of comorbidities that make him susceptible to fungal proliferation, related to the impairment of the immune system caused by type 2 diabetes mellitus and infections such as SARS-CoV-2.
Downloads
References
Andrade, E. A., Pinho, C. M., Tavares, A. B., Andrade, C. H. S., Silva, V. C. da, Andrade, C. C. S., Farias, W. S. de, Conceição, A. E. da, & Lima, P. da S. (2023). Perfil de pacientes com aspergilose pulmonar em hospital de referência em pneumologia em Recife/PE. Revista Eletrônica Acervo Saúde, 23(11), e13658. https://doi.org/10.25248/reas.e13658.2023
Arastehfar, A., et al. (2020). On behalf of the ECMM Working Group Immunologic Markers for Treatment Monitoring and Diagnosis in Invasive Mold Infection. (2020). COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment. Journal of Fungi. 6(2), 91. https://doi.org/10.3390/jof6020091
Bongomin, F., Harris, C., Hayes, G., Kosmidis, C., & Denning, D. W. (2018). Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PloS one, 13(4), e0193732. https://doi.org/10.1371/journal.pone.0193732
Bonfanti, J. W., Diniz Neto, H., Oliveira, H. C. d., Botelho, R. B. A., & Camargo, E. B. (2023). Acurácia da detecção do antígeno galactomanana no soro para o diagnóstico precoce de aspergilose pulmonar invasiva. Revista Científica da Escola Estadual de Saúde Pública de Goiás *Cândido Santiago*, 9, 1–26. https://doi.org/10.22491/2447-3405.2023.v9.9f0
Fernández-Trujillo, L., Eraso, I., Morales, E. I., & Sua, L. F. (2023). Invasive Aspergillosis in a Patient With Diabetes Mellitus as the Only Risk Factor: Case Report and Literature Review. Journal of investigative medicine high impact case reports, 11, 23247096231175443. https://doi.org/10.1177/23247096231175443
Flores, N. C. L., Marchiori, E., Capone, D., Alexandre, O. F. G., & de Miranda, F. N. (2024). COVID-19 associado à aspergilose: uma revisão. Brazilian Journal of Health Review, 7(1), 1523–1528. https://doi.org/10.34119/bjhrv7n1-116
Gervásio, F. M., Franco, J. V. V., Sampaio, A. de S., Passos, A. R. dos., Sakamoto, A. M., Silva, D. de S., Braz, D. C., Seixas, G. C., Spindola, L. A., & Abreu, T. M. de. (2022). Systematic review of COVID-19 associated with aspergillosis: perspectives for a new diagnosis. Research, Society and Development, 11(12), e204111234455. https://doi.org/10.33448/rsd-v11i12.34455
Huang, S. F., Ying-Jung Wu, A., Shin-Jung Lee, S., Huang, Y. S., Lee, C. Y., Yang, T. L., Wang, H. W., Chen, H. J., Chen, Y. C., Ho, T. S., Kuo, C. F., Lin, Y. T., & GREAT working group (2023). COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 56(3), 442–454. https://doi.org/10.1016/j.jmii.2022.12.004
John, T. M., Jacob, C. N., & Kontoyiannis, D. P. (2021). When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. Journal of fungi (Basel, Switzerland), 7(4), 298. https://doi.org/10.3390/jof7040298
Lescure, F. X., Bouadma, L., Nguyen, D., Parisey, M., Wicky, P. H., Behillil, S., Gaymard, A., Bouscambert-Duchamp, M., Donati, F., Le Hingrat, Q., Enouf, V., Houhou-Fidouh, N., Valette, M., Mailles, A., Lucet, J. C., Mentre, F., Duval, X., Descamps, D., Malvy, D., Timsit, J. F., Yazdanpanah, Y. (2020). Clinical and virological data of the first cases of COVID-19 in Europe: a case series. The Lancet. Infectious diseases, 20(6), 697–706. https://doi.org/10.1016/S1473-3099(20)30200-0
Mouro, H., & Inês Bueno de André Valery, M. (2023). Características clínicas e epidemiológicas de pacientes com aspergilose pulmonar crônica. Revista Científica do Iamspe, 12(3). https://ojs.iamspe.sp.gov.br/index.php/revistacientifica/article/view/145
Neufeld, P. M. (2020). A COVID-19 e o diagnóstico da aspergilose pulmonar invasiva. Revista Brasileira de Análises Clínicas, 52(2). https://doi.org/10.21877/2448-3877.20200019
Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM
Ramos, J. F., Hoffmann, T., Gomes, C. R., Colombo, E. S., & Ghilardi, F. (2022). Incidência de aspergilose invasiva em pacientes com diagnóstico de covid-19 grave internados em unidades críticas e semicríticas em um hospital privado brasileiro. The Brazilian Journal of Infectious Diseases, 26, 102408. https://doi.org/10.1016/j.bjid.2022.102408
Ramos, J. F., Cruz, I. C. V. D., Cortez, A. L., Freire, M. P., & Magri, M. C. (2021). Aspergilose pulmonar após covid‐19: serie de casos em pacientes críticos. The Brazilian Journal of Infectious Diseases, 25, 101430. https://doi.org/10.1016/j.bjid.2020.101430
Russo, A., Morrone, H. L., Rotundo, S., Trecarichi, E. M., & Torti, C. (2022). Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets. Diagnostics (Basel, Switzerland), 12(6), 1364. https://doi.org/10.3390/diagnostics12061364
Salmanton-García, J., Sprute, R., Stemler, J., Bartoletti, M., Dupont, D., Valerio, M., Garcia-Vidal, C., Falces-Romero, I., Machado, M., de la Villa, S., Schroeder, M., Hoyo, I., Hanses, F., Ferreira-Paim, K., Giacobbe, D. R., Meis, J. F., Gangneux, J. P., Rodríguez-Guardado, A., Antinori, S., Sal, E., FungiScope European Confederation of Medical Mycology/The International Society for Human and Animal Mycology Working Group (2021). COVID-19-Associated Pulmonary Aspergillosis, March-August 2020. Emerging infectious diseases, 27(4), 1077–1086. https://doi.org/10.3201/eid2704.204895
Silva Batista, C., de Souza Costa, L., & de Paula Mantovani, D. (2020). Aspergilose: Uma análise dos riscos de sua não notificação em ambientes hospitalares. Revista Transformar, 14(1), 448–473. https://www.fsj.edu.br/transformar/index.php/transformar/article/view/289/203
Sprute, R., Van Braeckel, E., Flick, H., Hoenigl, M., Kosmidis, C., Agarwal, R., Davidsen, J. R., Laursen, C. B., Cornely, O. A., & Seidel, D. (2022). EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis. The Journal of antimicrobial chemotherapy, 78(1), 225–231. https://doi.org/10.1093/jac/dkac378
Yang, A., Qiu, Q., Kong, X., Sun, Y., Chen, T., Zuo, Y., Yuan, D., Dai, W., Zhou, J., & Peng, A. (2020). Clinical and Epidemiological Characteristics of COVID-19 Patients in Chongqing China. Frontiers in public health, 8, 244. https://doi.org/10.3389/fpubh.2020.00244
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dilson Raimundo Gomes Pinheiro Neto; Gabriela de Lima Melo; Max Chaves Mota Junior; Rafael Hipólito Pires Batista ; Ícaro Natan da Silva Moraes; Rebeca Elise de Lima Pantoja; Paulo Afonso Oliveira Gomes ; Sofia Alessandra Naiff Araújo; Murilo Henrique Sousa e Souza; Kelrilem Rainara Manos Cruz; Isabella Lourenço Balla ; João Vitor Silva; Daniel Ferancini De La Cruz; Rossela Damasceno Caldeira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
